Peripheral facial nerve palsy associated with COVID-19

J Neurovirol. 2020 Dec;26(6):941-944. doi: 10.1007/s13365-020-00912-6. Epub 2020 Oct 2.


COVID-19 pandemic revealed several neurological syndromes related to this infection. We describe the clinical, laboratory, and radiological features of eight patients with COVID-19 who developed peripheral facial palsy during infection. In three patients, facial palsy was the first symptom. Nerve damage resulted in mild dysfunction in five patients and moderate in three. SARS-Cov-2 was not detected in CSF by PCR in any of the samples. Seven out of eight patients were treated with steroids and all patients have complete or partial recovery of the symptoms. Peripheral facial palsy should be added to the spectrum of neurological manifestations associated with COVID-19.

Keywords: Bell palsy; COVID-19; Facial nerve.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • COVID-19 / complications*
  • Facial Nerve / pathology
  • Facial Paralysis / drug therapy
  • Facial Paralysis / virology*
  • Female
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Prednisone / therapeutic use
  • SARS-CoV-2


  • Anti-Inflammatory Agents
  • Prednisone
  • Methylprednisolone